Health professionals for a new century: transforming education to strengthen health systems in an interdependent world J Frenk, L Chen, ZA Bhutta, J Cohen, N Crisp, T Evans, H Fineberg, ... The lancet 376 (9756), 1923-1958, 2010 | 7194 | 2010 |
Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2738 | 2021 |
Health-system reform and universal health coverage in Latin America R Atun, LOM De Andrade, G Almeida, D Cotlear, T Dmytraczenko, ... The Lancet 385 (9974), 1230-1247, 2015 | 848 | 2015 |
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in … DR Brown, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ... The Journal of infectious diseases 199 (7), 926-935, 2009 | 705 | 2009 |
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women N Muñoz, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ... Journal of the National Cancer Institute 102 (5), 325-339, 2010 | 477 | 2010 |
Manson's Tropical Infectious Diseases J Farrar, PJ Hotez, T Junghanss, G Kang, D Lalloo, NJ White, PJ Garcia Elsevier health sciences, 2023 | 419 | 2023 |
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, CM Wheeler, ... Cancer prevention research 2 (10), 868-878, 2009 | 411 | 2009 |
Serology testing in the COVID-19 pandemic response RW Peeling, CJ Wedderburn, PJ Garcia, D Boeras, N Fongwen, ... The Lancet Infectious Diseases 20 (9), e245-e249, 2020 | 376 | 2020 |
Diagnostics for COVID-19: moving from pandemic response to control RW Peeling, DL Heymann, YY Teo, PJ Garcia The Lancet 399 (10326), 757-768, 2022 | 373 | 2022 |
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in … CM Wheeler, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ... The Journal of infectious diseases 199 (7), 936-944, 2009 | 345 | 2009 |
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 271 | 2022 |
The Lancet Commission on diagnostics: transforming access to diagnostics KA Fleming, S Horton, ML Wilson, R Atun, K DeStigter, J Flanigan, ... The Lancet 398 (10315), 1997-2050, 2021 | 248 | 2021 |
COVID-19 response in Latin America PJ Garcia, A Alarcón, A Bayer, P Buss, G Guerra, H Ribeiro, K Rojas, ... The American journal of tropical medicine and hygiene 103 (5), 1765, 2020 | 241 | 2020 |
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine EA Joura, SK Kjaer, CM Wheeler, K Sigurdsson, OE Iversen, ... Vaccine 26 (52), 6844-6851, 2008 | 238 | 2008 |
Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean M Almonte, G Albero, M Molano, C Carcamo, PJ García, G Pérez Vaccine 26, L16-L36, 2008 | 226 | 2008 |
Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilis DC Mabey, KA Sollis, HA Kelly, AS Benzaken, E Bitarakwate, ... PLoS medicine 9 (6), e1001233, 2012 | 211 | 2012 |
Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities DT Jamison, A Alwan, CN Mock, R Nugent, D Watkins, O Adeyi, S Anand, ... The Lancet 391 (10125), 1108-1120, 2018 | 209 | 2018 |
Corruption in global health: the open secret PJ García The Lancet 394 (10214), 2119-2124, 2019 | 206 | 2019 |
Bartonellosis (Carrion's disease) in the modern era C Maguiña, PJ García, E Gotuzzo, L Cordero, DH Spach Clinical infectious diseases 33 (6), 772-779, 2001 | 206 | 2001 |
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection SE Olsson, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ... Human vaccines 5 (10), 696-704, 2009 | 190 | 2009 |